These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6273175)

  • 21. Detection of viral proteins in mouse mammary tumors by immunoperoxidase staining of paraffin sections.
    Keydar I; Mesa-Tejada R; Ramanarayanan M; Ohno T; Fenoglio C; Hu R; Spiegelman S
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1524-8. PubMed ID: 206904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural & immunological characteristics of murine mammary tumour virus of strain ICRC from primary tumour cell cultures.
    Saranath D; Chiplunkar SV; Karande KA
    Indian J Biochem Biophys; 1982 Dec; 19(6):426-8. PubMed ID: 6307861
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular immunity to the mammary tumour virus in mice bearing primary mammary tumours.
    Creemers P; Bentvelzen P
    Eur J Cancer (1965); 1977 Jun; 13(6):503-10. PubMed ID: 69543
    [No Abstract]   [Full Text] [Related]  

  • 24. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
    Tagliabue A; Herberman RB; McCoy JL
    Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
    [No Abstract]   [Full Text] [Related]  

  • 25. Exogenous and endogenous mouse mammary tumor virus superantigens.
    Acha-Orbea H; Held W; Waanders GA; Shakhov AN; Scarpellino L; Lees RK; MacDonald HR
    Immunol Rev; 1993 Feb; 131():5-25. PubMed ID: 8387457
    [No Abstract]   [Full Text] [Related]  

  • 26. Radioimmunoassays that demonstrate type-specific and group-specific antigenic reactivities for the major internal structural protein of murine mammary tumor viruses.
    Teramoto YA; Schlom J
    Cancer Res; 1978 Jul; 38(7):1990-5. PubMed ID: 77723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous immunity to mammary-tumour virus (MTV)-associated antigens in mice and its influence on syngeneic mammary-tumour growth.
    Müller M; Zotter S
    Eur J Cancer (1965); 1972 Oct; 8(5):495-500. PubMed ID: 4346866
    [No Abstract]   [Full Text] [Related]  

  • 28. [Location of viral antigens in mouse mammary adenocarcinoma by immunoperoxidase].
    Thomas JA; Garzon S; Lambré C
    C R Acad Hebd Seances Acad Sci D; 1973 Jul; 277(4):457-62. PubMed ID: 4362169
    [No Abstract]   [Full Text] [Related]  

  • 29. Murine mammary tumor virus protein vaccine: induction of antivirus immunity and inhibition or acceleration of growth of transplanted mammary tumors.
    Creemers P; Ouwehand J; Bentvelzen P
    J Natl Cancer Inst; 1977 Sep; 59(3):895-903. PubMed ID: 197247
    [No Abstract]   [Full Text] [Related]  

  • 30. An antigen cross-reactive with gp52 of mammary tumor virus is expressed on a B cell subpopulation of mice.
    Tax A; Ewert D; Manson LA
    J Immunol; 1983 May; 130(5):2368-71. PubMed ID: 6300244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A radioimmunoassay for MTV-antigens.
    Verstraeten AA; Hageman PC; Kwa HG
    Eur J Cancer (1965); 1973 Feb; 9(2):155-7. PubMed ID: 4352171
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoclonal and polyclonal antibody studies of VSV(hrMMTV) pseudotypes.
    Chan JC; East JL; Bowen JM; Massey R; Schochetman G
    Virology; 1982 Jul; 120(1):54-64. PubMed ID: 6179293
    [No Abstract]   [Full Text] [Related]  

  • 33. Distribution of mouse mammary tumour virus antigens in RIII mice as detected by immunofluorescence on tissue sections and by immunoassays in sera and organ extracts.
    Kozma S; Osterrieth PM; François C; Calberg-Bacq CM
    J Gen Virol; 1980 Dec; 51(Pt 2):327-39. PubMed ID: 6262440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sera from irradiated rats contain antibodies to a ubiquitous tumour-associated antigen.
    Bentvelzen P; Dubbeld MA; Koornstra WH; Broerse JJ; Van Zwieten MJ
    Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1255-63. PubMed ID: 6311562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological and biochemical characterization of the mouse mammary tumor virus with localization of p10.
    Cardiff RD; Puentes MJ; Young LJ; Smith GH; Teramoto YA; Altrock BW; Pratt TS
    Virology; 1978 Mar; 85(1):157-67. PubMed ID: 205999
    [No Abstract]   [Full Text] [Related]  

  • 36. Titrations of various mouse mammary tumor viruses in different mouse strains.
    Moore DH; Charney J; Holben JA
    J Natl Cancer Inst; 1974 Jun; 52(6):1757-61. PubMed ID: 4365388
    [No Abstract]   [Full Text] [Related]  

  • 37. Failure to induce protection against transplanted mammary tumours by vaccination with the purified murine mammary tumour virus structural proteins gp52 and p28.
    Creemers P; Westenbrink F; Brinkhof J; Bentvelzen P
    Eur J Cancer (1965); 1979 May; 15(5):679-84. PubMed ID: 228941
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunization of mice against murine mammary tumor virus infection and mammary tumor development.
    Sarkar NH; Moore DH
    Cancer Res; 1978 May; 38(5):1468-72. PubMed ID: 205366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procedures for radioimmunoassay of the mouse mammary tumor virus.
    Sheffield JB; Daly T; Dion AS; Taraschi N
    Cancer Res; 1977 May; 37(5):1480-5. PubMed ID: 192451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain-specific determinants on the major phosphoprotein of murine mammary tumor viruses.
    Racevskis J; Sarkar NH
    Virology; 1983 Feb; 125(1):230-5. PubMed ID: 6187126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.